Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS)…
Rare Disease Day … The Power of Many Voices
Rare Disease Day unites this wide range of conditions under one shared…
Survival in Uncertain Times
Like so many seasoned industry professionals, we eagerly seek thought leader perspectives — on the current biopharma industry landscape; the…
Professionalism Still Matters
Sadly, another summer is coming to a close. If you have school-aged kids at home, you are undoubtedly already taking steps to shake them out of…
Be Bold, Be Empowered
Coming up the ranks in various roles, I remember feeling frustrated at times when leadership would not “decide” or “give direction.” We were all…
Optimize Your Congress Planning
Regardless of your company or drug development stage, congress events are critical undertakings; they represent both a substantial opportunity and a…
Communicating Without a Communications Leader
Many of our clients are emerging companies striving towards their first clinical development program in anticipation of delivering on a promise to…
Forecast Models: It’s Not All About the Numbers
What is the difference between strategic thinking in quantifying the future and Excel gymnastics? This was a distinction I needed to learn in my…
Appreciation for Interconnectedness
It was March 2020 when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that…
Finding Partners in Biopharma: Standing Out in a Field of Many
When biopharma executives or business development leaders think about developing their “partnering story,” the focus is often on the innovation.…
Gaining Participation in Clinical Trials
When it comes to patient recruitment and retention for clinical trials, the bottom line is simply this: It is important and challenging in all…